[go: up one dir, main page]

BR0009289A - Uso de inibidores da vasopeptidase para tratar angina pectoris - Google Patents

Uso de inibidores da vasopeptidase para tratar angina pectoris

Info

Publication number
BR0009289A
BR0009289A BR0009289-4A BR0009289A BR0009289A BR 0009289 A BR0009289 A BR 0009289A BR 0009289 A BR0009289 A BR 0009289A BR 0009289 A BR0009289 A BR 0009289A
Authority
BR
Brazil
Prior art keywords
angina pectoris
vasopeptidase inhibitors
treat angina
vasopeptidase
inhibitors
Prior art date
Application number
BR0009289-4A
Other languages
English (en)
Inventor
James R Powell
Henry H Holzgrefe
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BR0009289A publication Critical patent/BR0009289A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"USO DE INIBIDORES DA VASOPEPTIDASE PARA TRATAR ANGINA PECTORIS". Inibidores de vasopeptidase, particularmente omapatrilat, são utilizáveis no tratamento e/ou alívio dos sintomas de angina pectoris. O inibidor de vasopeptidase pode ser usado em combinação com outros agentes farmaceuticamente aceitáveis.
BR0009289-4A 1999-03-29 2000-03-09 Uso de inibidores da vasopeptidase para tratar angina pectoris BR0009289A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12694299P 1999-03-29 1999-03-29
PCT/US2000/006091 WO2000057883A1 (en) 1999-03-29 2000-03-09 Use of vasopeptidase inhibitors to treat angina pectoris

Publications (1)

Publication Number Publication Date
BR0009289A true BR0009289A (pt) 2002-01-22

Family

ID=22427490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009289-4A BR0009289A (pt) 1999-03-29 2000-03-09 Uso de inibidores da vasopeptidase para tratar angina pectoris

Country Status (17)

Country Link
US (1) US6140319A (pt)
EP (1) EP1165088A4 (pt)
JP (1) JP2002540157A (pt)
KR (1) KR20020002487A (pt)
CN (1) CN1347321A (pt)
AU (1) AU768880B2 (pt)
BR (1) BR0009289A (pt)
CA (1) CA2368616A1 (pt)
CZ (1) CZ20013453A3 (pt)
HK (1) HK1039894A1 (pt)
HU (1) HUP0200662A3 (pt)
IL (1) IL144285A0 (pt)
MX (1) MXPA01009654A (pt)
NO (1) NO20014697D0 (pt)
RU (1) RU2245147C2 (pt)
WO (1) WO2000057883A1 (pt)
ZA (1) ZA200107962B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040198839A1 (en) * 2000-08-23 2004-10-07 Dean Herbert M. Cardioprotective dosage units
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
JP2005516940A (ja) * 2001-12-20 2005-06-09 ブリストル−マイヤーズ　スクイブ　カンパニー 高血圧患者に対する血管ペプチダーゼ阻害剤投与による脈圧と血管硬化度の低下
WO2008001311A2 (en) * 2006-06-26 2008-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
EP4356142A4 (en) * 2021-06-16 2025-07-23 Endothelium Scanning Nanotechnology Ltd BIOMARKERS AND DRUG COMBINATIONS FOR THE PREDICTION OF HEART FAILURE

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
CA2085993A1 (en) * 1990-06-22 1991-12-23 Andrew John Gilby Baxter Angiotensin converting enzyme inhibitors
GB9103454D0 (en) * 1991-02-19 1991-04-03 Pfizer Ltd Therapeutic agents
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
US5294632A (en) * 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
US5250522A (en) * 1992-10-09 1993-10-05 Ciba-Geigy Corporation Phosphono/biaryl substituted amino acid derivatives
US5244889A (en) * 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
DE69315808T2 (de) * 1992-11-17 1998-04-09 Smith & Nephew Inc Vorrichtung zur Befestigung von Nahtmaterial
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
EP0706525A1 (en) * 1993-06-30 1996-04-17 Novartis AG Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace
ATE193706T1 (de) * 1993-11-16 2000-06-15 Novartis Ag Zyklische aminosäure-derivate mit ace und nep inhibierender aktivität
AU1670995A (en) * 1994-01-28 1995-08-15 Cal International Limited A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
US5508266A (en) * 1994-06-22 1996-04-16 Ciba-Geigy Corporation Gem-disubstituted amino acid derivatives
FR2729668A1 (fr) * 1995-01-23 1996-07-26 Adir Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5744781A (en) * 1995-08-07 1998-04-28 General Electric Company Method and apparatus for laser shock peening
DE69926750T2 (de) * 1998-06-17 2006-06-29 Bristol-Myers Squibb Co. Vorbeugung des hirninfarkts durch kombinierte verabreichung von adp-rezeptor antiblutplättchen und antihypertensiven medikamenten

Also Published As

Publication number Publication date
AU3732100A (en) 2000-10-16
HK1039894A1 (zh) 2002-05-17
NO20014697L (no) 2001-09-27
AU768880B2 (en) 2004-01-08
EP1165088A4 (en) 2002-09-04
WO2000057883A1 (en) 2000-10-05
IL144285A0 (en) 2002-05-23
JP2002540157A (ja) 2002-11-26
HUP0200662A3 (en) 2004-07-28
KR20020002487A (ko) 2002-01-09
EP1165088A1 (en) 2002-01-02
US6140319A (en) 2000-10-31
NO20014697D0 (no) 2001-09-27
CN1347321A (zh) 2002-05-01
HUP0200662A2 (hu) 2002-07-29
MXPA01009654A (es) 2002-05-14
CZ20013453A3 (cs) 2002-02-13
ZA200107962B (en) 2003-01-02
RU2245147C2 (ru) 2005-01-27
CA2368616A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU2002302587A1 (en) Acne treatment with lipooxigenase inhibitors
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
TR199901604T2 (xx) Tedavide yararl� kinolin ve kinazolin bile�ikleri.
DK0891331T3 (da) N-(2-Oxoacetyl- eller sulfonyl)pyrrolidin/piperidin-2-carboxylsyrederivater med forbedret multi-lægemiddelresistensaktivitet
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
BR0014384A (pt) Compostos para o tratamento da isquémia
TR200103216T2 (tr) Pirimidinon bileşimleri
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
TR199901411T2 (xx) Analjezik etkili yeni bile�imler.
HUP0100586A2 (hu) Alsó húgyvezetéki tünetek kezelésére alkalmas gyógyászati készítmények
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
SE9902267D0 (sv) New compounds
BR0009289A (pt) Uso de inibidores da vasopeptidase para tratar angina pectoris
DE60124030D1 (de) Behandlung von Pansenacidose mit Amylasehemmern
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
TR200103151T2 (tr) Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon.
TR200000005T2 (tr) Sıtmaya karşı ß-alkoksiakrilatlar.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
BR0116554A (pt) Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
HKFN Application deemed withdrawn (deleted)
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.